Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intratympanic Steroid Injection for Treatment of Idiopathic Facial Nerve Paralysis

NCT03508440 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT03508440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03508440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intratympanic Steroid Injection for Treatment of Idiopathic Facial Nerve Paralysis
Lead sponsor
University of Missouri-Columbia
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2018
Completion date
June 1, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bell's palsy, facial nerve paresis